A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Dexys Midnight Runners founding member Andy Leek has died aged 66 after a battle with Parkinson's disease. He died on ...

Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Researchers Develop Analytical ...

Saying: 'Speaking is how I've earned my living for the best part of 50 years ... is available and what are the side effects?

Idiopathic Parkinson’s disease (IPD) is a central nervous system ... Further studies, including treatment trials, seem warranted.

Discover how traditional Chinese medicine is unlocking potential breakthroughs to dementia prevention and cognitive health.

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev ... infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson ...